Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BOSTON BIO SYSTEMS LTD.

NSE : NABSE : 531458ISIN CODE : INE109B01019Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE6.970.13 (+1.9 %)

PREV CLOSE ( ) 6.84

OPEN PRICE ( ) 6.97

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 100

TODAY'S LOW / HIGH ( )6.97 6.97

52 WK LOW / HIGH ( ) 6.5322

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-04 1995

Management Info

- Chairman Ghanshyam Dhananjay Gavali - Managing Director

Registered Office

Address A 828 Sun West Bank,Opp. City Gold Cinema,Ashram Road,
Ahmedabad,
Gujarat-380009

Phone 9806021223 / 9327781515 / 9098433517

Email bostonsystem@yahoo.com

Website www.bostonbiosystemltd.com

Registrars Details

Adroit Corporate Services Pvt Ltd

19, Jaferbhoy Industrial Estate ,Makwana Road, Marol Naka,Andheri (E),Mumbai

Listing : BSE

NEWS

24Jun Boston Bio Systems informs about clos
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as..

16May Boston Bio Systems informs about annua
Boston Bio Systems has informed that pursuant to Regulation 34 of SEBI (..

12May Boston Bio Systems informs about outco
In Pursuant to Regulation 30 of the Securities and Exchange Board of Ind..

14Nov Boston Bio Systems informs about outco
Boston Bio Systems has informed that Board of directors of the company a..

20May Boston Bio Systems informs about board
Boston Bio Systems has informed that a Meeting of Board of Directors of..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	-4.91	-5.48
Gross Profit	-4.91	-5.48
Operating Profit	-4.91	-5.48
Net Sales	1.92	1.92

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

KMS Medisurgi (BSE) 126.50 (4.98%)	M.Cap ( in Cr)41.75
Centenial Surgical (BSE) 158.45 (1.57%)	M.Cap ( in Cr)57.81
Raaj Medisafe India (BSE) 100.00 (0.57%)	M.Cap ( in Cr)132.13
Kretto Syscon (BSE) 2.00 (-0.50%)	M.Cap ( in Cr)125.44
GKB Ophthalmics (BSE) 74.02 (-2.61%)	M.Cap ( in Cr)37.31

Shareholding Pattern

	NON-INSTITUTION	97.86%
	PROMOTERS	2.14%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

BOSTON BIO SYSTEMS LTD.